^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    DRP®-5FU

    Company:
    Allarity Therap
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    Allarity’s DRP®-5FU is a companion diagnostic (CDx) that has been retrospectively validated and shown to predict patient response to 5FU treatment in late-stage colorectal cancer.
    Cancer:
    Colorectal Cancer
    Drug:
    Deflexifol (5-fluorouracil/leucovorin)